Search





Search





Markets
/
Stocks
/
stro
/

Sutro Biopharma Inc

STRO

Add to Watchlist

24.170USD

-0.650-2.62%

Close 07-31 16:00（ET）Quotes delayed by 15 min

400.51MMarket Cap

LossP/E TTM

Sutro Biopharma Inc

24.170

-0.650-2.62%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

STRO Cash Flow Statement

You can access the annual and quarterly cash flow statements of Sutro Biopharma Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q1

FY2017Q4

FY2017Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

37.75%-42.26M

63.15%-26.43M

40.81%-38.19M

-573.02%-44.72M

-4.85%-67.88M

-609.79%-71.74M

-92.57%-64.52M

130.31%9.46M

-6.15%-64.74M

158.97%14.07M

-150.87%-33.50M

-879.13%-31.20M

-73.00%-60.99M

-10.58%-23.86M

369.83%65.85M

39.46%-3.19M

-15.86%-35.26M

-14.31%-21.58M

-37.97%-24.41M

57.90%-5.26M

-62.43%-30.43M

-43.50%-18.88M

-9.73%-17.69M

19.88%-12.50M

7.00%-18.73M

-121.67%-13.16M

-133.89%-16.12M

---15.60M

-34.21%-20.14M

-22.62%-5.94M

2434.30%47.57M

---15.01M

---4.84M

---2.04M

Net income from continuing operations

49.34%-38.48M

35.45%-46.76M

-16.54%-56.86M

76.05%-11.50M

-30.50%-75.97M

-333.20%-72.44M

1.01%-48.79M

-24.64%-48.02M

-16.31%-58.21M

189.80%31.07M

-152.89%-49.28M

-48.10%-38.52M

-27.97%-50.05M

9.26%-34.59M

36.94%-19.49M

-322.82%-26.01M

-28.83%-39.11M

35.97%-38.13M

-280.30%-30.90M

-120.59%-6.15M

-54.93%-30.36M

-302.62%-59.54M

232.74%17.14M

316.57%29.87M

-37.51%-19.59M

-890.56%-14.79M

-26.13%-12.91M

---13.79M

-18.30%-14.25M

90.27%-1.49M

-621.93%-10.24M

---12.05M

---15.34M

---1.42M

Operating gains losses

-32.74%1.28M

77.62%3.32M

5.61%1.90M

6.15%1.90M

7.89%1.90M

7.91%1.87M

3.45%1.80M

3.41%1.79M

9.04%1.76M

13.29%1.73M

20.93%1.74M

23.91%1.73M

21.70%1.61M

16.20%1.53M

28.62%1.44M

24.73%1.40M

2.79%1.33M

12.20%1.31M

15.62%1.12M

5.76%1.12M

17.47%1.29M

-3.70%1.17M

-21.45%967.00K

-11.16%1.06M

-3.34%1.10M

7.22%1.22M

10.01%1.23M

--1.19M

-2.15%1.14M

-71.16%1.14M

-6.44%1.12M

--1.16M

--3.94M

--1.20M

Other non-cash items

5.45%10.33M

23.31%10.68M

57.74%10.57M

70.99%10.19M

64.92%9.79M

91.19%8.66M

34.19%6.70M

1066.13%5.96M

612.78%5.94M

1343.96%4.53M

643.96%4.99M

-167.73%-617.00K

-186.42%-1.16M

-113.80%-364.00K

-86.09%671.00K

-4.41%911.00K

155.73%1.34M

190.34%2.64M

190.49%4.83M

-60.42%953.00K

1088.68%524.00K

-2639.13%-2.92M

5636.67%1.66M

5023.40%2.41M

1.85%-53.00K

112.00%115.00K

-107.30%-30.00K

--47.00K

-173.97%-54.00K

-32033.33%-958.00K

87.67%411.00K

--73.00K

--3.00K

--219.00K

Change in working capital

-85.24%-16.94M

129.74%4.68M

165.29%4.65M

-204.57%-50.58M

44.96%-9.15M

27.09%-15.73M

-290.27%-7.12M

514.23%48.37M

31.93%-16.62M

-210.30%-21.58M

-95.32%3.74M

-21.92%7.88M

-367.38%-24.41M

524.68%19.57M

5581.63%79.98M

464.64%10.09M

68.40%-5.22M

43.28%3.13M

86.48%-1.46M

-27760.00%-2.77M

-471.47%-16.53M

197.90%2.19M

-48.28%-10.79M

100.20%10.00K

66.62%-2.89M

64.52%-2.23M

-112.97%-7.28M

---5.09M

-94.13%-8.66M

-198.37%-6.29M

2215.53%56.13M

---4.46M

--6.40M

---2.65M

-Change in receivables

-72.00%-8.51M

97.20%-55.00K

1282.03%4.08M

-77.15%5.56M

-203.52%-4.95M

89.92%-1.96M

104.45%295.00K

19425.40%24.35M

273.68%4.78M

-571.20%-19.45M

-107.67%-6.63M

99.85%-126.00K

-458.20%-2.75M

3429.03%4.13M

2826.50%86.43M

-4348.27%-85.98M

146.04%768.00K

-106.44%-124.00K

-33.14%-3.17M

-148.60%-1.93M

40.02%-1.67M

56.04%1.92M

-130.94%-2.38M

225.77%3.98M

-227.56%-2.78M

2780.43%1.23M

-239.14%-1.03M

---3.16M

66.46%-849.00K

-100.50%-46.00K

107.63%741.00K

---2.53M

--9.23M

---9.72M

-Change in prepaid expenses

-9218.18%-1.00M

171.81%4.98M

412.50%7.95M

1994.77%6.41M

100.46%11.00K

-935.72%-6.93M

-393.20%-2.54M

-95.83%306.00K

67.81%-2.39M

-10.95%-669.00K

130.35%868.00K

2603.07%7.33M

-3601.89%-7.42M

-204.87%-603.00K

-491.24%-2.86M

86.71%-293.00K

106.93%212.00K

163.68%575.00K

212.12%731.00K

-3901.72%-2.21M

-315.95%-3.06M

41.10%-903.00K

-107.64%-652.00K

-17.14%58.00K

321.73%1.42M

-16.22%-1.53M

50.94%-314.00K

--70.00K

358.46%336.00K

-2436.54%-1.32M

-67.54%-640.00K

---130.00K

---52.00K

---382.00K

-Change in other current liabilities

70.02%-1.96M

98.54%-145.00K

9.21%-6.13M

-318.40%-58.67M

25.20%-6.53M

66.34%-9.95M

-341.41%-6.76M

618.83%26.86M

-66.37%-8.73M

-486.20%-29.56M

154.87%2.80M

-105.62%-5.18M

-659.59%-5.25M

448.18%7.65M

-36.43%-5.10M

3334.57%92.06M

113.38%938.00K

-43.01%-2.20M

63.98%-3.74M

21.64%-2.85M

-553.72%-7.01M

62.49%-1.54M

-44.91%-10.38M

6.73%-3.63M

131.45%1.54M

44.65%-4.10M

-112.91%-7.16M

---3.89M

-89.43%-4.91M

-168.16%-7.40M

855.47%55.50M

---2.59M

---2.76M

--5.81M

Cash from non-recurring investing activities

Cash from operating activities

37.75%-42.26M

63.15%-26.43M

40.81%-38.19M

-573.02%-44.72M

-4.85%-67.88M

-609.79%-71.74M

-92.57%-64.52M

130.31%9.46M

-6.15%-64.74M

158.97%14.07M

-150.87%-33.50M

-879.13%-31.20M

-73.00%-60.99M

-10.58%-23.86M

369.83%65.85M

39.46%-3.19M

-15.86%-35.26M

-14.31%-21.58M

-37.97%-24.41M

57.90%-5.26M

-62.43%-30.43M

-43.50%-18.88M

-9.73%-17.69M

19.88%-12.50M

7.00%-18.73M

-121.67%-13.16M

-133.89%-16.12M

---15.60M

-34.21%-20.14M

-22.62%-5.94M

2434.30%47.57M

---15.01M

---4.84M

---2.04M

Investing cash flow

Net cash from continuing investing activities

-99.06%11.00K

-82.77%184.00K

-69.69%251.00K

-88.62%86.00K

163.23%1.17M

-25.88%1.07M

152.44%828.00K

-52.87%756.00K

-52.65%446.00K

-57.20%1.44M

-55.56%328.00K

-27.09%1.60M

-39.34%942.00K

32.72%3.37M

-85.23%738.00K

-59.36%2.20M

-34.64%1.55M

56.12%2.54M

67.97%5.00M

206.51%5.41M

211.40%2.38M

-20.69%1.63M

346.03%2.98M

261.15%1.77M

176.45%763.00K

156.77%2.05M

85.79%667.00K

--489.00K

-24.18%276.00K

21.46%798.00K

-58.30%359.00K

--364.00K

--657.00K

--861.00K

Capital expenditures

-99.06%11.00K

-82.77%184.00K

-69.69%251.00K

-88.62%86.00K

163.23%1.17M

-25.88%1.07M

152.44%828.00K

-52.87%756.00K

-52.65%446.00K

-57.20%1.44M

-55.56%328.00K

-27.09%1.60M

-39.34%942.00K

32.72%3.37M

-85.23%738.00K

-59.36%2.20M

-34.64%1.55M

56.12%2.54M

67.97%5.00M

206.51%5.41M

211.40%2.38M

-20.69%1.63M

346.03%2.98M

261.15%1.77M

176.45%763.00K

156.77%2.05M

85.79%667.00K

--489.00K

-24.18%276.00K

21.46%798.00K

-58.30%359.00K

--364.00K

--657.00K

--861.00K

Net cash flow from disposal of fixed assets

-99.06%11.00K

-82.77%184.00K

-69.69%251.00K

-88.62%86.00K

163.23%1.17M

-25.88%1.07M

152.44%828.00K

-52.87%756.00K

-52.65%446.00K

-57.20%1.44M

-55.56%328.00K

-27.09%1.60M

-39.34%942.00K

32.72%3.37M

-85.23%738.00K

-59.36%2.20M

-34.64%1.55M

56.12%2.54M

67.97%5.00M

206.51%5.41M

211.40%2.38M

-20.69%1.63M

346.03%2.98M

261.15%1.77M

176.45%763.00K

156.77%2.05M

85.79%667.00K

--489.00K

-24.18%276.00K

21.46%798.00K

-58.30%359.00K

--364.00K

--657.00K

--861.00K

Net cash flow from investment products

-200.01%-45.25M

-78.67%18.89M

-45.67%40.24M

103.35%2.67M

-123.37%-15.08M

501.21%88.56M

165.15%74.07M

-217.50%-79.62M

-5.62%64.55M

64.76%-22.07M

-45.90%-113.69M

35.21%67.76M

98.04%68.39M

-368.73%-62.64M

-2928.46%-77.92M

343.93%50.12M

128.93%34.53M

34.40%23.31M

-15.77%2.75M

120.39%11.29M

-381.50%-119.35M

73.59%17.34M

-68.79%3.27M

-671.83%-55.37M

154.50%42.40M

253.91%9.99M

112.86%10.48M

--9.68M

---77.80M

23.44%2.82M

-1263.66%-81.46M

--0.00

--2.29M

--7.00M

Net cash flow from other investing activities

--0.00

----

--0.00

--74.05M

----

-100.00%0.00

----

312377.78%28.12M

--625.00K

----

-89.89%9.00K

----

--89.00K

----

--17.00K

Cash from non-current investing activities

Net cash flow from investing activities

-178.41%-45.26M

-78.62%18.70M

-72.85%39.99M

103.21%2.58M

-125.36%-16.26M

472.08%87.49M

229.18%147.29M

-221.49%-80.38M

-4.96%64.11M

37.93%-23.51M

-46.11%-114.02M

38.07%66.16M

104.51%67.45M

-282.29%-37.88M

-3380.69%-78.04M

715.44%47.91M

127.09%32.98M

31.47%20.78M

-857.43%-2.24M

110.28%5.88M

-392.36%-121.73M

99.03%15.81M

-96.98%296.00K

-721.45%-57.14M

153.33%41.64M

292.20%7.94M

111.99%9.81M

--9.19M

-21350.27%-78.08M

24.23%2.02M

-1429.03%-81.81M

---364.00K

--1.63M

--6.16M

Financing cash flow

Cash flow from continuous financing activities

156074.24%103.08M

-166.67%-64.00K

-89.97%102.00K

-100.06%-60.00K

101.92%66.00K

99.23%-24.00K

117.72%1.02M

-29.91%96.49M

-139.15%-3.43M

-125.57%-3.13M

-119.23%-5.74M

2409.77%137.66M

1052.37%8.76M

2315.22%12.22M

2999.38%29.85M

14164.10%5.49M

-58.38%760.00K

-99.65%506.00K

-94.42%963.00K

-100.04%-39.00K

-88.37%1.83M

8237.87%144.85M

1632.56%17.27M

11262.27%91.42M

3528.38%15.70M

-102.03%-1.78M

-102.25%-1.13M

---819.00K

-3171.43%-458.00K

49735.59%87.86M

239.52%50.17M

---14.00K

---177.00K

--14.78M

Net cash flow from debt Issuance/repayment

----

--0.00

100.00%0.00

-30.66%-4.08M

0.00%-3.13M

---3.13M

--0.00

-100.00%0.00

100.00%0.00

3100.00%15.00M

---1.50M

---500.00K

----

--0.00

----

Net cash flow from common stock issuance/repurchase

--103.13M

----

--0.00

9110.59%96.53M

-100.00%0.00

----

-100.00%0.00

-87.81%1.05M

--10.92M

219314.29%15.35M

--32.33M

--8.60M

----

-100.00%-7.00K

-100.00%0.00

----

--143.16M

--16.84M

--91.41M

----

-100.00%0.00

----

--84.57M

----

--0.00

--14.96M

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

----

-100.00%0.00

--51.52M

----

--95.00K

--0.00

Proceeds from stock option exercised by employees

-55.69%109.00K

--3.00K

-88.36%127.00K

--0.00

-76.07%246.00K

--0.00

14.36%1.09M

--0.00

-27.14%1.03M

-100.00%0.00

37.86%954.00K

-100.00%0.00

18.97%1.41M

-99.81%1.00K

-34.22%692.00K

-99.56%2.00K

-46.89%1.19M

-69.63%513.00K

40.83%1.05M

5550.00%452.00K

218.09%2.23M

3493.62%1.69M

822.22%747.00K

-20.00%8.00K

1571.43%702.00K

137.30%47.00K

-79.44%81.00K

--10.00K

10.53%42.00K

---126.00K

545.90%394.00K

--38.00K

----

--61.00K

Proceeds from issuance of warrants

----

---2.00K

--2.00K

----

Net cash flow from other financing activities

11.11%-160.00K

-179.17%-67.00K

66.22%-25.00K

-62.16%-60.00K

51.87%-180.00K

---24.00K

97.93%-74.00K

-100.03%-37.00K

17.07%-374.00K

--0.00

-7038.00%-3.57M

1074807.69%139.74M

-5.87%-451.00K

--0.00

43.82%-50.00K

102.65%13.00K

-4.67%-426.00K

--0.00

71.66%-89.00K

---491.00K

---407.00K

100.00%0.00

-207.53%-314.00K

----

-109.58%-327.00K

116.73%292.00K

--671.00K

100.00%0.00

1354.78%3.41M

-612.24%-1.75M

---52.00K

---272.00K

---245.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

156074.24%103.08M

-166.67%-64.00K

-89.97%102.00K

-100.06%-60.00K

101.92%66.00K

99.23%-24.00K

117.72%1.02M

-29.91%96.49M

-139.15%-3.43M

-125.57%-3.13M

-119.23%-5.74M

2409.77%137.66M

1052.37%8.76M

2315.22%12.22M

2999.38%29.85M

14164.10%5.49M

-58.38%760.00K

-99.65%506.00K

-94.42%963.00K

-100.04%-39.00K

-88.37%1.83M

8237.87%144.85M

1632.56%17.27M

11262.27%91.42M

3528.38%15.70M

-102.03%-1.78M

-102.25%-1.13M

---819.00K

-3171.43%-458.00K

49735.59%87.86M

239.52%50.17M

---14.00K

---177.00K

--14.78M

Net cash flow

Beginning cash balance

-69.14%58.99M

-61.93%66.78M

-29.20%64.88M

62.07%107.09M

172.54%191.16M

112.12%175.44M

-61.16%91.64M

4.31%66.08M

45.74%70.14M

-15.30%82.71M

195.01%235.97M

112.76%63.34M

53.83%48.13M

209.23%97.65M

39.68%79.99M

-47.48%29.77M

-84.89%31.29M

-51.60%31.58M

-12.39%57.26M

30.08%56.69M

4061.29%207.02M

445.09%65.24M

236.84%65.36M

63.64%43.58M

-96.03%4.97M

-71.07%11.97M

-23.71%19.41M

--26.63M

468.70%125.31M

62.73%41.37M

289.75%25.43M

--22.04M

--25.42M

--6.53M

Current period cash flow changes

118.50%15.55M

-149.58%-7.80M

-97.73%1.90M

-265.05%-42.20M

-1968.27%-84.08M

225.15%15.73M

154.67%83.79M

-85.19%25.57M

-126.71%-4.07M

74.63%-12.57M

-967.65%-153.26M

243.77%172.62M

1105.82%15.22M

-16802.73%-49.52M

168.77%17.66M

8648.08%50.21M

98.99%-1.51M

-100.21%-293.00K

-21127.27%-25.68M

-97.36%574.00K

-489.42%-150.33M

2127.19%141.78M

98.37%-121.00K

401.45%21.78M

139.12%38.60M

-108.33%-6.99M

-146.67%-7.44M

---7.23M

-541.29%-98.68M

2578.45%83.94M

-15.68%15.93M

---15.39M

---3.39M

--18.90M

Ending cash balance

-30.39%74.54M

-69.14%58.99M

-61.93%66.78M

-29.20%64.88M

62.07%107.09M

172.54%191.16M

112.12%175.44M

-61.16%91.64M

4.31%66.08M

45.74%70.14M

-15.30%82.71M

195.01%235.97M

112.76%63.34M

53.83%48.13M

209.23%97.65M

39.68%79.99M

-47.48%29.77M

-84.89%31.29M

-51.60%31.58M

-12.39%57.26M

30.08%56.69M

4061.29%207.02M

445.09%65.24M

236.84%65.36M

63.64%43.58M

-96.03%4.97M

-71.07%11.97M

--19.41M

300.65%26.63M

468.70%125.31M

62.73%41.37M

--6.65M

--22.04M

--25.42M

Free cash flow

38.79%-42.27M

63.44%-26.62M

41.17%-38.44M

-615.12%-44.81M

-5.94%-69.06M

-676.41%-72.81M

-93.15%-65.34M

126.52%8.70M

-5.25%-65.19M

146.38%12.63M

-151.95%-33.83M

-508.97%-32.80M

-68.26%-61.93M

-12.91%-27.23M

321.46%65.12M

49.55%-5.39M

-12.20%-36.81M

-17.62%-24.12M

-42.29%-29.40M

25.16%-10.68M

-68.26%-32.81M

-34.85%-20.50M

-23.09%-20.66M

11.34%-14.27M

4.52%-19.50M

-125.83%-15.21M

-135.56%-16.79M

---16.09M

-32.83%-20.42M

-22.48%-6.73M

1728.63%47.21M

---15.37M

---5.50M

---2.90M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Sutro Biopharma Inc Generate?



Sutro Biopharma Inc generated -177.23M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Sutro Biopharma Inc's Operating Cash Flow Change Year Over Year?



Sutro Biopharma Inc's operating cash flow increased by 7.47% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Sutro Biopharma Inc Spend on Capital Expenditures?



Sutro Biopharma Inc spent 1.70M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Sutro Biopharma Inc's Financing Cash Flow Changed?



Sutro Biopharma Inc used 44.00K in financing activities in the latest quarter.

What is free cash flow and why does it matter for STRO?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Sutro Biopharma Inc’s free cash flow in the latest quarter?



Free cash flow was -178.93M reflecting a 8.07% change from the previous year.